RECORNA
Latest round
- Angel
Last raised
- Jun 2024
Total raised
- Undisclosed
Investors
- 7
About RECORNA
Based in Guangzhou, China, and founded in 2021, RECORNA is a drug company that focuses on developing targeted RNA editing technology. The R&D center has been set up in the US. The company was awarded Best Enterprise of Innovative Pharmaceuticals in 2023 and the Second Prize in the Fifth Guangzhou Women. The company specializes in developing innovative drugs through targeted RNA editing technologies for cardiovascular and cerebrovascular diseases, neurological diseases, respiratory diseases, and other areas. It has established R&D platforms, including drug discovery, biological validation, delivery system development, etc. The company generates revenue by providing research and development services for RNA editing technology.
Who invested in RECORNA
7 investors across 2 rounds
See all investors in RECORNA
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about RECORNA
Who invested in RECORNA?
RECORNA has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RECORNA raised?
RECORNA has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did RECORNA last raise money?
RECORNA's most recent round on record is a Angel, in Jun 2024.
What does RECORNA do?
Based in Guangzhou, China, and founded in 2021, RECORNA is a drug company that focuses on developing targeted RNA editing technology.
Where is RECORNA headquartered?
RECORNA is headquartered in Guangzhou, China.
Which VCs invest in companies like RECORNA?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at RECORNA's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like RECORNA? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.